Methylxanthine for the prevention and treatment of apnea in preterm infants [Protocol]

Keri Marques, Charles C. Roehr, Matteo Bruschettini, Peter G. Davis, Roger Soll

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To determine the effects of methylxanthine administration on the incidence of apnea and longer-term clinical outcomes in preterm infants including infants at risk for or having apnea and preterm infants peri-extubation.

Original languageEnglish
Article numberCD013830
JournalCochrane Database of Systematic Reviews
Volume2020
Issue number12
DOIs
Publication statusPublished - 2021

Subject classification (UKÄ)

  • Pediatrics

Fingerprint

Dive into the research topics of 'Methylxanthine for the prevention and treatment of apnea in preterm infants [Protocol]'. Together they form a unique fingerprint.

Cite this